Home Equities Score AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of...

AIM ImmunoTech Inc. (AIM) Stock Undergoes Minor Volatility After Announcing Extension of Collaboration with Smoore

AIM ImmunoTech Inc. (AIM) stock prices were down by 1.42% as of the market closing on May 28th, 2021, bringing the price per share down to USD$2.08 at the end of the trading day. Subsequent pre-market fluctuations have seen the stock fall by 2.40%, bringing it down to USD$2.03.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Extension of Agreement with Smoore

May 27th, 2021 saw the company announce the extension of its Material Transfer and Research Agreement with Shenzhen Smoore Technology Ltd by two years. The collaboration with the subsidiary of Smoore International Holdings Ltd aims to develop Ampligen as a potential inhalation therapy for Covid-19 and other respiratory viral diseases. The agreement was entered into by AIM on April 1st, 2020, with the aim of studying the utilization of a new Smoore inhalation delivery device and Ampligen as a prospective treatment approach for the coronavirus pandemic.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

Ampligen Development

Concurrently, the past year has seen the company focus on the development of a personal inhalation device designed to administer Ampligen, given temperature parameters of dsRNA. More recently, AIM has used an ex vivo 3D model in primary human respiratory epithelial cells at Utah State University to study the safety and efficacy of Ampligen. The study showed Ampligen as being able to lower Covid-19 infectious viral yields by 90% at clinically viable intranasal Ampligen dosage levels. Having conducted relevant intranasal safety testing, AIM forecasts commencing inhalation safety testing before the end of 2021.

Scope of Ampligen

On account of the readiness for the development of the concept or an Ampligen inhalation delivery device and the company’s track record of high safety and efficacy, AIM is pushing for the further development and commercialization of Ampligen. With the world hurtling towards global immunizations, the company hopes to address a portion of that market and for Ampligen to also treat other respiratory viral diseases that will have a scope beyond the pandemic. The company is currently in the process of planning a Phase 1/1 inhalation clinical study that will operate in tandem with Smoore’s device development testing.

Partnership Merits

One of the Smoore’s focal points for research and development is the application of vaping technology in healthcare and pharmaceutical fields. Their collaboration with AIM will explore applications of advanced atomization technology in relation to medical inhalation therapy. Smoore will coordinate its device development efforts in conjunction with AIM’s plan and the regulation needs to move into next phase testing on schedule.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for AIM

With the extension of the collaboration with Smoore, AIM has consolidated a potentially prosperous several quarter ahead of it. The company is poised to capitalize on the joint efforts of the parties involved to facilitate further growth. Current and potential investors are hopeful that the company will manage to leverage the resources at their disposal to usher in significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Why BancorpSouth Bank (BXS) stock plummeted on Friday?

BancorpSouth Bank (BXS) shares plummeted 9.39% in after-hours on Friday, June 18, 2021, and close the weekly business at $25.00 per share. Earlier, BXS's...

CureVac Inc. (CVAC) stock soar during pre-market trading. Here’s what you should know?

CureVac Inc. (NASDAQ: CVAC) stock declined by 38.99% at the last close while the CVAC stock price gains by 11.34% in the pre-market trading...

Why Iconix Brand Group Inc (ICON) stock turnaround in the after-hours on Thursday?

Iconix Brand Group Inc (ICON) shares started the Thursday, June 17, 2021, trading be losing 1.87% and close the normal trading session at $3.14...

The9 Ltd. (NCTY) stock declined during pre-market trading. Here’s the update

The9 Ltd. (NASDAQ: NCTY) stock plunged by 12% at the last close while the NCTY stock price fell by 7.03% during pre-market trading. The9...

The Dixie Group Inc. (DXYN) stock surged during pre-market trading given no recent news

The Dixie Group Inc. (NASDAQ: DXYN) stock gained by 11.55% in the pre-market trading session. However, there is no update available regarding this hike...

Why Eyenovia Inc. (EYEN) stock price went up in the after-market on Friday?

Eyenovia Inc. (EYEN) shares pop up 8.41% in after-hours on Friday, June 18, 2021, and close the week at $5.80 per share. Earlier, EYEN's...

Related News

Anavex Inc. (AVXL) stock soars during pre-market trading. Let’s see why?

Anavex Inc. (AVXL) stock gained by 4.29% at the last close while the AVXL stock price surged by 12.38% in the pre-market trading session....

IM Cannabis Corp. (IMCC) stock surged during after-hour session. Why is it so?

IM Cannabis Corp. (NASDAQ: IMCC) stock gained by 3.01% at last close while the IMCC stock price rises by 7.19% in the after-hours session....

Victory Capital Holdings Inc. (VCTR) stock declined in the after-hour session. Here’s what you should know?

Victory Capital Holdings Inc. (NASDAQ: VCTR) stock declined by 1.89% at the last close while the VCTR stock price plunged by 0.76% in the...

Anpac Bio-Medical Science Inc. (ANPC) stock soars during pre-market trading. Here’s the update

Anpac Bio-Medical Science Inc. (NASDAQ: ANPC) stock gained by 0.46% at last close while the ANPC stock price surged by 22.40% in the pre-market...

Arrival Inc. (ARVL) stock falls during pre-market trading. Here’s what you should know?

Arrival Inc. (NASDAQ: ARVL) stock plunged by 4.96% at last close while the ARVL stock price declines by 9.68% in the pre-market trading session....

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam